Literature DB >> 7380485

Methods for the estimation of pyrazinamide and pyrazinoic acid in body fluids.

P Gurumurthy, N G Nair, G R Sarma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7380485

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN： 0971-5916            Impact factor:   2.375


× No keyword cloud information.
  3 in total

1.  Decreased bioavailability of rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease.

Authors:  Prema Gurumurthy; Geetha Ramachandran; A K Hemanth Kumar; S Rajasekaran; C Padmapriyadarsini; Soumya Swaminathan; S Bhagavathy; P Venkatesan; L Sekar; A Mahilmaran; N Ravichandran; P Paramesh
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

2.  Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis.

Authors:  Qurrat Ul-Ain; Sadhna Sharma; G K Khuller
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

3.  The blood/cerebrospinal fluid partitioning of pyrazinamide: a study during the course of treatment of tuberculous meningitis.

Authors:  P Phuapradit; K Supmonchai; S Kaojarern; C Mokkhavesa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.